System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Joël Eyer is an expert in Biochemistry at Centre Hospitalier Universitaire d'Angers (France). Joël Eyer has authored 79 publications, the most recent in 2025. SLR score: 350 (community average: 125). How the SLR is computed.

LeadR Profile

Joël Eyer Centre Hospitalier Universitaire d'Angers France
350 ScienceLeadR Reputation 350

Unlock

Register Login
Network Map

Biochemistry

Subspecialties: Pharmacy - Oncology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1998 - 2025
Source: PubMed

INSERM

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 79

Citations

Citations: 2 211 1st author: 2 Last author: 36 Unique author: 1

Main journals

HAL (Le Centre pour la Communication Scientifique Directe) 11
Int J Pharm X 5
Int J Pharm 4
J Neurosci Res 4
Biomaterials 3

Best Journals

Cell 1
Nature 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Corrigendum to 'Biological activity of gold nanoparticles combined with the NFL-TBS.40-63 peptide, or with other cell penetrating peptides, on rat glioblastoma cells' [International Journal of Pharmaceutics: X 4 (2022) 100129].
PMID 41497305 — cell-penetrating peptides, cells, biopharmaceutics, nanoparticles, glioblastoma		Int J Pharm X20250
Development of a potential nano-based delivery system combining Colchicine-loaded lipid nanocapsules and BIOT-NFL-peptide to target glioblastoma.
PMID 40933608 — cells, colchicine, neoplasms, glioblastoma, therapeutics, microtubules, nanocapsules		Int J Pharm X20250
Doxorubicin-NFL-TBS.40-63 peptide Gold Complex Nanovector (DOX IN-NFL@AuNPs): Efficacy Evaluation in a mouse transplantation tumor model induced by PANC-1/ADR human pancreatic cancer resistant strain cells.
PMID 40568371 — cells, pancreatic neoplasms, doxorubicin, neoplasms, therapeutics, transplantation		Nanotheranostics20250
Doxorubicin and NFL-TBS.40-63 peptide loaded gold nanoparticles as a multimodal therapy of glioblastoma.
PMID 40293574 — nanoparticles, pharmaceutical preparations, doxorubicin, glioblastoma, therapeutics		Discov Nano20250
One-Step Synthesis of Poly(2-alkyl-2-oxazoline)-Coated Gold Nanospheres: A Greener Approach for Biomedical Uses.
PMID 40008451 — polymers, biological science disciplines, nanoparticles, nanospheres		Biomacromolecules20250

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS